GLP-1 Drugs: Government Issues Advisory, Lists Benefits; Severe And Rare Side Effects Amid Weight-Loss Hype

The Government of India has issued an advisory on the regulatory framework for GLP-1 (Glucagon-Like Peptide-1) drugs, prescription medications used to manage type 2 diabetes and obesity. Unsupervised sales by pharmacies and wellness clinics have led to the issuance of comprehensive guidelines to regulate drug supply more strictly.

Government Regulations

As per the new circular, only qualified specialists are authorised to prescribe GLP-1 drugs. The government also bans deceptive advertisements, taking into account unauthorised sales of the medicine nationwide, and action will be taken against illegal suppliers such as pharmacies, clinics, and warehouses.

ALSO READ | Weight Loss Drugs Boom: Wellness Platforms Advertise Treatment Plans, But Is It Legal?

Non-compliance will be liable for fines, licence cancellation, and legal action for violations. The DCGI's latest advisory underscores the necessity of strict compliance among healthcare providers and pharmacists to curb misuse and prioritise patient safety.

GLP-1 drugs have shown successful treatment in managing type 2 diabetes and obesity, but due to adverse side effects, the medicines should be closely supervised.

GLP-1 Drugs Use, Risks, and Regulation

Diabetes is a chronic disease that occurs when the pancreas does not produce adequate insulin, or when the body cannot effectively use the insulin it produces, leading to high blood sugar. If left untreated, it can lead to complications… pic.twitter.com/neafj4Sjic

— PIB India (@PIB_India) April 1, 2026

Side-effects of GLP-1 drugs

As the consumption of GLP-1 drugs can lead to severe health complications, it must be taken under medical supervision.

The diabetes management drug poses adverse reactions, including nausea and dizziness to pancreatitis and medullary thyroid cancer, against which government intervention is essential for long-term healthy life.

Diabetes Decoded: Type 1 vs. Type 2
Diabetes is primarily classified into two distinct types, each impacting the body's physiology differently.

Type 1 Diabetes: This autoimmune condition occurs when the pancreas produces little to no insulin. As a result, patients are insulin-dependent and require daily administration for life.

Type 2 Diabetes: Characterised by insulin resistance, this type occurs when the body cannot effectively use the insulin it produces. Primary risk factors include genetic predisposition, physical inactivity, and obesity.

ALSO READ | The Weight Loss Price Cut Begins — NATCO Launches Semaglutide At Rs 1,290

GLP-1 Drug Breakthrough and Mechanism

GLP-1 medicine effects have emerged as a dual-action treatment for both type 2 diabetes and obesity. When we consume food, the body naturally activates GLP-1 to trigger insulin release and suppress glucagon, which prevents the liver from releasing extra glucose. GLP-1 medications mimic this natural hormone but with longer-lasting effects:

Blood Sugar Control: They stimulate the pancreas to produce more insulin, bringing glucose levels back to baseline.

Appetite Suppression: These drugs slow gastric emptying, meaning food remains in the digestive tract longer. This increases the sensation of fullness and reduces overall caloric intake, leading to weight loss.

Prevention Strategies for Type 2 Diabetes:

Obesity is a chronic disease resulting from excess body fat. Maintaining health involves five critical lifestyle pillars:

1. Weight Management: Achieving and sustaining a healthy body mass.
2. Physical Activity: Engaging in at least 150 minutes of moderate exercise weekly.
3. Nutritional Discipline: Prioritising a healthy diet while eliminating tobacco and excessive saturated fats.
4. Sugar Reduction: Actively avoiding refined sugars.
5. Through calorie counting: Increasing the intake of whole grains, legumes, fruits, and nuts.

Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.